2017
DOI: 10.1016/j.fsigen.2017.04.010
|View full text |Cite
|
Sign up to set email alerts
|

Differentially methylated embryonal Fyn-associated substrate (EFS) gene as a blood-specific epigenetic marker and its potential application in forensic casework

Abstract: DNA methylation patterns have the ability to reveal the activities of genes within a certain tissue at a particular time point. Tissue-specific DNA methylation patterns have been previously investigated for their applicability in the identification of forensically relevant body fluids, however there is still a lack in robust markers. While following a genome-wide scale investigation has a great potential to reveal useful tissue-specific changes, a gene-targeted approach can also lead to significant outcomes, e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 37 publications
0
9
0
Order By: Relevance
“…Hence, the future development of a fast and cheap laboratory tool that allows the reliable targeted analysis of the 13 CpGs highlighted here by employing a technology that can handle low quality and/or quantity DNA would be valuable. Foreseeing the future development of such a lab tool, we only included CpGs with at least a ÎČ-value difference ≄ 10% in mean or median (depending on availability per EWAS) in at least one published EWAS, to ensure detectability of the DNA methylation differences with targeted analysis technologies currently available [77,78]. We view the positive results on epigenetic inference of smoking habits from blood presented here as a promising starting point for inferring more lifestyle factors using DNA methylation markers within the concept of epigenetic fingerprinting [17].…”
Section: Discussionmentioning
confidence: 99%
“…Hence, the future development of a fast and cheap laboratory tool that allows the reliable targeted analysis of the 13 CpGs highlighted here by employing a technology that can handle low quality and/or quantity DNA would be valuable. Foreseeing the future development of such a lab tool, we only included CpGs with at least a ÎČ-value difference ≄ 10% in mean or median (depending on availability per EWAS) in at least one published EWAS, to ensure detectability of the DNA methylation differences with targeted analysis technologies currently available [77,78]. We view the positive results on epigenetic inference of smoking habits from blood presented here as a promising starting point for inferring more lifestyle factors using DNA methylation markers within the concept of epigenetic fingerprinting [17].…”
Section: Discussionmentioning
confidence: 99%
“…Subsequently, several studies have been published using various DNA methylation loci and analysis methods for different forensically relevant tissues [ 30 – 33 ]. Reported genes include FOXO3 and EFS for blood [ 32 , 34 ], SLC12A8 and BCAS4 for saliva [ 30 , 34 ], DACT1 and C12orf12 for semen [ 31 , 35 ], LOC404266 and HOXD9 for vaginal secretion [ 34 ], and SLC26A10 and LTBP3 for menstrual blood [ 13 ]. The reliable epigenetic determination of more complex body fluids such as menstrual blood can be more challenging, mainly due to the combination of different cell types and smaller methylation effects of currently proposed markers [ 13 ].…”
Section: Current Progress In Forensic Epigeneticsmentioning
confidence: 99%
“…Currently, some laboratories are testing low template input material to determine if the quantity of input DNA required for accurate and reliable methylation analysis can be reduced . However, recent studies have highlighted the influence of stochastic effects on the methylation results of low template samples . The use of replicates and statistical models incorporating the expected level of variability are needed for reliable interpretation of the data in these circumstances.…”
Section: Massively Parallel Sequencingmentioning
confidence: 99%